Hot Pursuit     19-May-23
KIMS Q4 PAT jumps 16% YoY to Rs 93 cr
Krishna Institute Medical Science (KIMS) reported 15.6% rise in consolidated net profit to Rs 93.27 core in Q4 FY23 as compared with Rs 80.68 crore in Q4 FY22.
Revenue from operations for the quarter jumped 54.68% year on year to Rs 575.92 crore.

Reported EBITDA (including other income) stood at Rs 168.13 crore in Q4 FY23, registering the growth of 38.1% as compared with Rs 121.76 crore posted in corresponding quarter last year.

On operational front, In patient (IP) volumes stood at Rs 45,056 (up 38.3%YoY), Out patient (OP) volumes was at Rs 3,80,850 (up 40.6% YoY), average revenue per operating bed (ARPOB) stood at Rs 30,573 (up 21.6% YoY), average revenue per patient (ARPP) was at Rs 1,27,916 (up 10.9% YoY).

On full year basis, the company's net profit rose 1.9% to Rs 336.32 crore on 33.13% jump in revenue from operations to Rs 2,197.67 crore in FY23 over FY22.

B. Bhaskara Rao, chairman & managing director, said, “The last quarter of FY 23 saw us deliver our best-ever Quarterly numbers. It is a testimony to the continued trust of patients in KIMS's quality of service, and clinical excellence, and delivering the same with affordability. We continue to focus on identifying experienced clinical talents across specialties and geographies and adding new therapies which will help us drive growth in the coming quarters

Our digital automation project to deliver an even better patient experience is progressing at a brisk pace. I am confident we will keep the momentum going in FY24 to deliver patient satisfaction and financial growth together.”

Meanwhile, Vikas Maheshwari has tendered his resignation as the chief financial officer (CFO) of the company due to personal reasons. The board accepted his resignation and accordingly, Vikas Maheshwari will stand relieved from the closure of business hours on 31 May 2023.

Headquartered in Hyderabad, KIMS Hospitals is one of the largest corporate healthcare groups in Telangana and Andhra Pradesh, providing multi-disciplinary integrated healthcare services, with a focus on tertiary and quaternary healthcare at affordable cost. It has a network of 12 hospitals and 3940 beds spread across Telangana, Andhra Pradesh and Maharashtra.

The scrip fell 0.04% to Rs 1533.70 on the BSE.

Previous News
  Krishna Institute of Medical Sciences consolidated net profit declines 6.41% in the December 2022 quarter
 ( Results - Announcements 10-Feb-23   07:38 )
  KIMS announces sale of its step-down subsidiary Suryateja Healthcare
 ( Corporate News - 13-Jan-23   18:17 )
  Krishna Institute of Medical Sciences consolidated net profit declines 29.81% in the March 2024 quarter
 ( Results - Announcements 16-May-24   18:25 )
  Krishna Institute of Medical Sciences acquires land for new hospital in Thane
 ( Corporate News - 14-Mar-24   18:51 )
  KIMS slips as Q3 PAT slides 6% YoY To Rs 72 cr
 ( Hot Pursuit - 05-Feb-24   12:22 )
  KIMS Hospitals declines after Q4 PAT falls nearly 30% YoY to Rs 65 crore
 ( Hot Pursuit - 17-May-24   11:33 )
  Volumes jump at CIE Automotive India Ltd counter
 ( Hot Pursuit - 05-Feb-24   11:00 )
  Krishna Institute of Medical Sci. schedules board meeting
 ( Corporate News - 28-Oct-22   11:01 )
  Krishna Institute of Medical Sciences consolidated net profit declines 2.11% in the September 2021 quarter
 ( Results - Announcements 30-Nov-21   16:44 )
  Krishna Institute of Medical Sciences consolidated net profit rises 700.81% in the June 2021 quarter
 ( Results - Announcements 11-Aug-21   07:51 )
  Krishna Institute of Medical Sciences
 ( IPO Centre - New Issue Monitor 15-Jun-21   13:45 )
Other Stories
  Metal stocks edge lower
  08-Jul-24   14:01
  Basic materials shares fall
  08-Jul-24   14:01
  Consumer Durables stocks slide
  08-Jul-24   14:00
  Central Bank of India eases for fifth straight session
  08-Jul-24   13:36
  Apollo Tyres Ltd eases for fifth straight session
  08-Jul-24   13:35
  Reliance Industries Ltd up for third straight session
  08-Jul-24   13:06
  Oil & Natural Gas Corpn Ltd rises for third consecutive session
  08-Jul-24   13:05
  Zydus Lifesciences Ltd spurts 0.43%, up for five straight sessions
  08-Jul-24   13:01
  Dr Reddys Laboratories Ltd gains for fifth session
  08-Jul-24   13:01
  HPL Electric soars after inking MoU with China-based Guangxi Ramway Tech
  08-Jul-24   12:40
Back Top